Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice
2007/02/14 by D G Bailey, David G. Bailey, G K Dresser +4 · 30 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Drug Transport and Resistance Mechanisms #Pharmacological Effects and Toxicity Studies #Pharmacogenetics and Drug Metabolism
paper · doi:10.1038/sj.clpt.6100104
Abstract
We showed previously that grapefruit and orange juices inhibited human enteric organic anion-transporting polypeptide (OATP)1A2 in vitro and lowered oral fexofenadine bioavailability clinically. Inhibition of OATP1A2 transport by flavonoids in grapefruit (naringin) and orange (hesperidin) was conducted in vitro. Two randomized, crossover, pharmacokinetic studies were performed clinically. In one study, 120 mg of fexofenadine was ingested with 300 ml grapefruit juice, an aqueous solution of naringin at the same juice concentration (1,200 microM), or water. In the other study, fexofenadine was administered with grapefruit juice, with or 2 h before aqueous suspension of the particulate fraction of juice containing known clinical inhibitors of enteric CYP3A4, but relatively low naringin concentration (34 microM), or with water. Naringin and hesperidin's half-maximal inhibitions were 3.6 and 2.7 microM, respectively. Fexofenadine area under the plasma drug concentration-time curves (AUCs) with grapefruit juice and naringin solution were 55% (P<0.001) and 75% (P<0.05) of that with water, respectively. Fexofenadine AUCs with grapefruit juice and particulate fractions were 57% (P<0.001), 96% (not significant (NS)), and 97% (NS) of that with water, respectively. Individuals tested in both studies (n=9 of 12) had highly reproducible fexofenadine AUC with water (r(2)=0.85, P<0.001) and extent of reduction of it with grapefruit juice (r(2)=0.72, P<0.01). Naringin most probably directly inhibited enteric OATP1A2 to decrease oral fexofenadine bioavailability. Inactivation of enteric CYP3A4 was probably not involved. Naringin appears to have sufficient safety, specificity, and sensitivity to be a clinical OATP1A2 inhibitor probe. Inherent OATP1A2 activity may be influenced by genetic factors. This appears to be the first report of a single dietary constituent clinically modulating drug transport.
Citations
Cited by
- Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion–Transporting Polypeptides
- Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers
- Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1
- Major Active Components in Grapefruit, Orange, and Apple Juices Responsible for OATP2B1-Mediated Drug Interactions
- Solute carriers (SLCs) in cancer
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. [europepmc]
- Xenobiotic, bile acid, and cholesterol transporters: function and regulation. [europepmc]
- Marginal increase of sunitinib exposure by grapefruit juice. [europepmc]
- Influence of dietary substances on intestinal drug metabolism and transport. [europepmc]
- The effect of grapefruit juice on drug disposition. [europepmc]
- Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A). [europepmc]
- Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions. [europepmc]
- Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics. [europepmc]
- Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. [europepmc]
- Rapid Quantitation of Furanocoumarins and Flavonoids in Grapefruit Juice using Ultra-Performance Liquid Chromatography. [europepmc]
- Organic anion-transporting polypeptides. [europepmc]
- Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways. [europepmc]
- Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles. [europepmc]
- Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science. [europepmc]
- The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions. [europepmc]
- Transport Properties of Statins by Organic Anion Transporting Polypeptide 1A2 and Regulation by Transforming Growth Factor- β Signaling in Human Endothelial Cells. [europepmc]
- Food-Drug Interactions with Fruit Juices. [europepmc]
- Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity. [europepmc]
- Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery. [europepmc]
- Thyroid Hormone Transporters in a Human Placental Cell Model. [europepmc]
- Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs). [europepmc]
- Polyphenolic promiscuity, inflammation-coupled selectivity: Whether PAINs filters mask an antiviral asset. [europepmc]
- The protective roles of citrus flavonoids, naringenin, and naringin on endothelial cell dysfunction in diseases. [europepmc]
- Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition. [europepmc]
- Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders. [europepmc]
Related